Clinical Trial Update: TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update reporting the pharmacokinetics of moxifloxacin during tuberculosis treatment (TBTC Study 27/28); the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Moxifloxacin (moxifloxacin)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED